Article
Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Sept 2008
Lightfoot Tracy J, Barrett Jennifer H, Bishop Timothy, Northwood Emma L, Smith Gillian, Wilkie Murray J V, Steele Robert J C, Carey Francis A, Key Tim J, Wolf Roland, Forman David
Abstract excerpt
Epidemiologic evidence suggests a role for folate, a critical component of the 1-carbon cycle, in colorectal adenoma and cancer pathogenesis. Low folate levels, along with genetic polymorphisms in key enzymes such as methylene tetrahydrofolate reductase (MTHFR), can cause DNA hypomethylation and aberrant CpG methylation, which have been associated with colorectal tumor development. We investigated self-reported...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
